Wei Gen Lu
Direktor/Vorstandsmitglied bei Shanghai Innostar Biotechnology Co., Ltd.
Profil
Wei Gen Lu is currently a Director at Shanghai Innostar Biotechnology Co., Ltd.
He previously worked as a Director at Shanghai Shyndec Pharmaceutical Co., Ltd.
Dr. Lu holds a doctorate degree from East China University of Science & Technology and an undergraduate degree from China Pharmaceutical University.
Aktive Positionen von Wei Gen Lu
Unternehmen | Position | Beginn |
---|---|---|
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.10.2017 |
Ehemalige bekannte Positionen von Wei Gen Lu
Unternehmen | Position | Ende |
---|---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Wei Gen Lu
China Pharmaceutical University | Undergraduate Degree |
East China University of Science & Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Commercial Services |